Biosysen Limited

Research Biosysen Limited (1355.HK) on Bullrun: market cap HKD 370.45M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 370.45M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025HKD 51.31M-HKD 43.53M-HKD 49.61M65.8%n/aHKD 2.44MHKD 162.19M-HKD 35.25M
FY2024HKD 40.68M-HKD 21.12MHKD 24.01M98.1%-0.03HKD 13.86MHKD 164.99M-HKD 42.36M
FY2023HKD 67.66M-HKD 38.18MHKD 34.51M100.0%-0.07HKD 2.21MHKD 181.60M-HKD 36.35M
FY2022HKD 63.00M-HKD 7.79MHKD 6.41Mn/a-0.01HKD 2.43MHKD 175.86MHKD 2.18M
FY2021n/an/an/an/a0.01n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 370.45Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Biosysen Limited

Biosysen Limited, an investment holding company, engages in the accommodation operation and property facilities management services in the People's Republic of China. It also provides accommodation consultancy and management, and engages in healthcare and beauty business, which offers bioregenerative, collagen, and anti-aging skincare products.

Related stock research

Other Consumer Cyclical stocks

Frequently asked questions

What is Biosysen Limited's market cap?

Biosysen Limited's market capitalization is HKD 370.45M.

What does Biosysen Limited do?

Biosysen Limited, an investment holding company, engages in the accommodation operation and property facilities management services in the People's Republic of China. It also provides accommodation consultancy and management, and engages in healthcare and beauty business, which offers bioregenerative, collagen, and anti-aging skincare products. The company also offers property facilities outsourcing management services, such as professional cleaning, sterilisation, inventory supply management, and quality management to third party customers.